BMY logo

Bristol-Myers Squibb (BMY) Cash and cash equivalents

annual cash & cash equivalents:

$10.35B-$1.12B(-9.75%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BMY annual cash & cash equivalents is $10.35 billion, with the most recent change of -$1.12 billion (-9.75%) on December 31, 2024.
  • During the last 3 years, BMY annual cash & cash equivalents has fallen by -$3.63 billion (-25.99%).
  • BMY annual cash & cash equivalents is now -28.87% below its all-time high of $14.55 billion, reached on December 31, 2020.

Performance

BMY Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYbalance sheet metrics

quarterly cash & cash equivalents:

$10.88B+$529.00M(+5.11%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BMY quarterly cash & cash equivalents is $10.88 billion, with the most recent change of +$529.00 million (+5.11%) on March 31, 2025.
  • Over the past year, BMY quarterly cash & cash equivalents has increased by +$1.54 billion (+16.56%).
  • BMY quarterly cash & cash equivalents is now -64.33% below its all-time high of $30.49 billion, reached on September 30, 2019.

Performance

BMY quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMYbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

BMY Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-9.8%+16.6%
3 y3 years-26.0%-12.1%
5 y5 years-16.2%-31.2%

BMY Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-26.0%+13.4%-12.1%+72.8%
5 y5-year-28.9%+13.4%-45.4%+72.8%
alltimeall time-28.9%+1928.6%-64.3%+2032.3%

BMY Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$10.88B(+5.1%)
Dec 2024
$10.35B(-9.8%)
$10.35B(+31.1%)
Sep 2024
-
$7.89B(+25.4%)
Jun 2024
-
$6.29B(-32.6%)
Mar 2024
-
$9.33B(-18.6%)
Dec 2023
$11.46B(+25.7%)
$11.46B(+52.6%)
Sep 2023
-
$7.51B(-10.2%)
Jun 2023
-
$8.37B(-6.9%)
Mar 2023
-
$8.99B(-1.4%)
Dec 2022
$9.12B(-34.7%)
$9.12B(+18.0%)
Sep 2022
-
$7.73B(-28.1%)
Jun 2022
-
$10.75B(-13.1%)
Mar 2022
-
$12.37B(-11.5%)
Dec 2021
$13.98B(-3.9%)
$13.98B(+3.2%)
Sep 2021
-
$13.54B(+22.8%)
Jun 2021
-
$11.02B(+0.4%)
Mar 2021
-
$10.98B(-24.5%)
Dec 2020
$14.55B(+17.8%)
$14.55B(-25.2%)
Sep 2020
-
$19.43B(-2.5%)
Jun 2020
-
$19.93B(+26.0%)
Mar 2020
-
$15.82B(+28.1%)
Dec 2019
$12.35B(+78.6%)
$12.35B(-59.5%)
Sep 2019
-
$30.49B(+7.3%)
Jun 2019
-
$28.40B(+287.2%)
Mar 2019
-
$7.33B(+6.1%)
Dec 2018
$6.91B(+27.5%)
$6.91B(+27.8%)
Sep 2018
-
$5.41B(+8.2%)
Jun 2018
-
$5.00B(-6.4%)
Mar 2018
-
$5.34B(-1.5%)
Dec 2017
$5.42B(+27.9%)
$5.42B(+16.7%)
Sep 2017
-
$4.64B(+33.8%)
Jun 2017
-
$3.47B(-11.3%)
Mar 2017
-
$3.91B(-7.7%)
Dec 2016
$4.24B(+77.7%)
$4.24B(+23.5%)
Sep 2016
-
$3.43B(+17.0%)
Jun 2016
-
$2.93B(+11.0%)
Mar 2016
-
$2.64B(+10.9%)
Dec 2015
$2.38B(-57.2%)
$2.38B(-40.0%)
Sep 2015
-
$3.98B(-5.3%)
Jun 2015
-
$4.20B(-33.3%)
Mar 2015
-
$6.29B(+13.0%)
Dec 2014
$5.57B(+55.4%)
$5.57B(+14.8%)
Sep 2014
-
$4.85B(+13.3%)
Jun 2014
-
$4.28B(-18.0%)
Mar 2014
-
$5.22B(+45.7%)
Dec 2013
$3.59B(+116.5%)
$3.59B(+102.5%)
Sep 2013
-
$1.77B(-2.7%)
Jun 2013
-
$1.82B(+34.4%)
Mar 2013
-
$1.35B(-18.2%)
Dec 2012
$1.66B(-71.3%)
$1.66B(+10.2%)
Sep 2012
-
$1.50B(-46.3%)
Jun 2012
-
$2.80B(+21.4%)
Mar 2012
-
$2.31B(-60.1%)
Dec 2011
$5.78B(+14.8%)
$5.78B(+29.2%)
Sep 2011
-
$4.47B(+22.0%)
Jun 2011
-
$3.67B(+7.6%)
Mar 2011
-
$3.40B(-32.3%)
Dec 2010
$5.03B(-34.5%)
$5.03B(-15.0%)
Jun 2010
-
$5.92B(+15.2%)
Mar 2010
-
$5.13B(-33.2%)
Dec 2009
$7.68B(-3.7%)
$7.68B(+20.7%)
Sep 2009
-
$6.37B(-15.2%)
Jun 2009
-
$7.51B(-4.1%)
Mar 2009
-
$7.83B(-1.8%)
Dec 2008
$7.98B(+342.9%)
$7.98B(+11.2%)
Sep 2008
-
$7.17B(+77.2%)
Jun 2008
-
$4.05B(+65.7%)
Mar 2008
-
$2.44B(+35.6%)
Dec 2007
$1.80B
$1.80B(+9.4%)
Sep 2007
-
$1.65B(-30.8%)
Jun 2007
-
$2.38B(+7.5%)
DateAnnualQuarterly
Mar 2007
-
$2.21B(+9.7%)
Dec 2006
$2.02B(-33.8%)
$2.02B(-28.8%)
Sep 2006
-
$2.83B(+8.9%)
Jun 2006
-
$2.60B(+5.0%)
Mar 2006
-
$2.48B(-18.8%)
Dec 2005
$3.05B(-17.1%)
$3.05B(+43.3%)
Sep 2005
-
$2.13B(+18.4%)
Jun 2005
-
$1.80B(-45.7%)
Mar 2005
-
$3.31B(-10.0%)
Dec 2004
$3.68B(+44.4%)
$3.68B(+8.8%)
Sep 2004
-
$3.38B(+7.1%)
Jun 2004
-
$3.16B(+3.0%)
Mar 2004
-
$3.06B(+20.2%)
Dec 2003
$2.55B(+7.7%)
$2.55B(-48.5%)
Sep 2003
-
$4.95B(+15.0%)
Jun 2003
-
$4.31B(-0.5%)
Mar 2003
-
$4.33B(+82.8%)
Dec 2002
$2.37B(-57.0%)
$2.37B(-33.5%)
Sep 2002
-
$3.56B(+0.4%)
Jun 2002
-
$3.55B(+4.9%)
Mar 2002
-
$3.38B(-38.5%)
Dec 2001
$5.50B(+72.8%)
$5.50B(+96.4%)
Sep 2001
-
$2.80B(-4.9%)
Jun 2001
-
$2.94B(+11.8%)
Mar 2001
-
$2.63B(-17.2%)
Dec 2000
$3.18B(+17.0%)
$3.18B(+15.3%)
Sep 2000
-
$2.76B(+24.2%)
Jun 2000
-
$2.22B(-10.0%)
Mar 2000
-
$2.47B(-9.3%)
Dec 1999
$2.72B(+21.2%)
$2.72B(+10.8%)
Sep 1999
-
$2.46B(+18.0%)
Jun 1999
-
$2.08B(+3.9%)
Mar 1999
-
$2.00B(-10.7%)
Dec 1998
$2.24B(+54.1%)
$2.24B(+46.6%)
Sep 1998
-
$1.53B(+52.3%)
Jun 1998
-
$1.00B(-35.8%)
Mar 1998
-
$1.56B(+7.5%)
Dec 1997
$1.46B(-13.4%)
$1.46B(-12.5%)
Sep 1997
-
$1.66B(+11.5%)
Jun 1997
-
$1.49B(-17.4%)
Mar 1997
-
$1.81B(+7.5%)
Dec 1996
$1.68B(+2.2%)
$1.68B(+22.9%)
Sep 1996
-
$1.37B(+21.7%)
Jun 1996
-
$1.12B(-13.9%)
Mar 1996
-
$1.30B(-20.7%)
Dec 1995
$1.65B(+0.2%)
$1.65B(-1.7%)
Sep 1995
-
$1.67B(-2.6%)
Jun 1995
-
$1.72B(-2.7%)
Mar 1995
-
$1.77B(+7.6%)
Dec 1994
$1.64B(-32.2%)
$1.64B(-10.9%)
Sep 1994
-
$1.84B(-16.2%)
Jun 1994
-
$2.20B(-12.8%)
Mar 1994
-
$2.52B(+4.2%)
Dec 1993
$2.42B(+13.3%)
$2.42B(+4.0%)
Sep 1993
-
$2.33B(+8.0%)
Jun 1993
-
$2.15B(+32.9%)
Mar 1993
-
$1.62B(-24.1%)
Dec 1992
$2.14B(+48.9%)
$2.14B(+121.0%)
Sep 1992
-
$967.00M(+18.8%)
Jun 1992
-
$814.00M(-30.5%)
Mar 1992
-
$1.17B(-18.3%)
Dec 1991
$1.44B(+140.8%)
$1.44B(+10.4%)
Sep 1991
-
$1.30B(+19.4%)
Jun 1991
-
$1.09B(+79.1%)
Mar 1991
-
$608.00M(+2.0%)
Dec 1990
$596.00M(+16.9%)
$596.00M(-48.6%)
Sep 1990
-
$1.16B(-5.0%)
Jun 1990
-
$1.22B(+30.7%)
Mar 1990
-
$934.00M(+83.1%)
Dec 1989
$510.00M(-79.7%)
$510.00M(-79.7%)
Dec 1988
$2.51B(+7.0%)
$2.51B(+7.0%)
Dec 1987
$2.35B
$2.35B

FAQ

  • What is Bristol-Myers Squibb annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb annual cash & cash equivalents year-on-year change?
  • What is Bristol-Myers Squibb quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Bristol-Myers Squibb?
  • What is Bristol-Myers Squibb quarterly cash & cash equivalents year-on-year change?

What is Bristol-Myers Squibb annual cash & cash equivalents?

The current annual cash & cash equivalents of BMY is $10.35B

What is the all time high annual cash & cash equivalents for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high annual cash & cash equivalents is $14.55B

What is Bristol-Myers Squibb annual cash & cash equivalents year-on-year change?

Over the past year, BMY annual cash & cash equivalents has changed by -$1.12B (-9.75%)

What is Bristol-Myers Squibb quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of BMY is $10.88B

What is the all time high quarterly cash & cash equivalents for Bristol-Myers Squibb?

Bristol-Myers Squibb all-time high quarterly cash & cash equivalents is $30.49B

What is Bristol-Myers Squibb quarterly cash & cash equivalents year-on-year change?

Over the past year, BMY quarterly cash & cash equivalents has changed by +$1.54B (+16.56%)
On this page